Kevin E Lofton is Director of GILEAD SCIENCES, INC.. Currently has a direct ownership of 8,442 shares of GILD, which is worth approximately $793,125. The most recent transaction as insider was on Mar 09, 2023, when has been sold 8,442 shares (Common Stock) at a price of $52.38 per share, resulting in proceeds of $442,191. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.44K
0% 3M change
0% 12M change
Total Value Held $793,125

Kevin E Lofton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2023
BUY
Exercise of conversion of derivative security
$442,191 $52.38 p/Share
8,442 Added 50.0%
8,442 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$418,620 $20.64 p/Share
20,282 Added 21.47%
74,203 Common Stock
Nov 23 2020
SELL
Bona fide gift
-
21,720 Reduced 28.71%
53,921 Common Stock

Also insider at

RAD
RITE AID CORP Healthcare
MDT
Medtronic plc Healthcare
KEL

Kevin E Lofton

Director
Camp Hill, PA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD